We tested the in vitro sensitivity of Macropodid Herpesvirus 2 to eight commonly used anti-herpetic compounds using plaque reduction tests, March and April, 1995. The virus was most susceptible to inhibition by (E)-5-(2′-bromovinyl)-2′-deoxyuridine and adenine 9-(β-D-arabino-furanoside. Both compounds have been used for anti-herpetic therapy in humans and may prove useful in the treatment of macropodoids in captivity.
How to translate text using browser tools
1 January 1996
In vitro Sensitivity of Macropodid Herpesvirus 2 to Selected Anti-Herpetic Compounds
G. Smith
Journal of Wildlife Diseases
Vol. 32 • No. 1
January 1996
Vol. 32 • No. 1
January 1996
antiviral dnigs
herpesvirus
kangaroos
Macropodid herpesvirus 2
macropodoids
treatment